Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity

In this Viewpoint, 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of GLP-1 (7-37), the biologically active incretin that led to development of effective GLP-1 analogues for treating diabetes and obesity.

Authors

Svetlana Mojsov (ORCID: https://orcid.org/0000-0002-3111-9923)

Institutions

Rockefeller University (US)

Publication Details

Journal: JAMA
Published: 2024-09-19
DOI: https://doi.org/10.1001/jama.2024.17571
Citations: 4
Primary Topic: Chemical Synthesis and Analysis
Type: article
Field-Weighted Citation Impact: 0.94

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity

Svetlana Mojsov

Sep 19, 2024

4 citations

JAMA

Chemical Synthesis and Analysis

0.94

article

Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity

Svetlana Mojsov

September 19, 2024article en

4 citations

Abstract

JAMAVol. 332(20)

Rockefeller University (US)

Good health and well-being

Openalex Percentile: Top 25%

Chemical Synthesis and Analysis

0.94

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity — Svetlana Mojsov · JAMA (2024) | TGRS Research Map | TGRS